Mnemosyne Pharmaceuticals

Healthcare 📍 Providence, United States 👥 11-50 employees 💰 $11.7M raised 📅 Founded 2010

Mnemosyne Pharmaceuticals, Inc. is developing an innovative drug discovery platform that will address medical needs in several segments of the mental health market. Mnemosyne was founded in 2010 with seed funding from Slater Technology Fund and private investors. Recently, Mnemosyne closed on a Series A round totaling

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

11-50

Total Raised · Venture

$11.7M

Founded

2010

Cloud

Unknown

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	🔒 Subscribers only
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K – $270K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from Mnemosyne Pharmaceuticals's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction